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1  Introduction
Currently, intrinsically disordered proteins (IDPs) [1,2] 
receive great attention from the scientific community. 
IDPs are indeed involved in many important physiological 
processes related to signaling and regulation of 
transcription [3], moreover, they take part in several 
human diseases [4,5]. 
IDPs are natively disordered proteins that lack in 
whole or in part a single organized three dimensional 
structure [1,2]. Recent studies indicate that in eukaryotes 
more than a third of the proteins are provided with 
intrinsically disordered regions (IDRs) that are made up 
of at least thirty residues [2]. It is thought that disorder 
is actually encoded in the primary sequence and that 
IDPs are generally enriched in certain types of amino-
acids [2,6]. Detailed studies relying on comparison 
of natively folded and natively unfolded proteins 
demonstrate that IDPs have generally a low content of 
“order-promoting” amino acids such as Ile, Leu, Val, 
Trp, Tyr, Phe, Cys, Asn, whereas, they are considerably 
enriched in “disorder-promoting” residues (i.e., Ala, 
Arg, Gly, Gln, Ser, Glu, Lys and Pro) [1]. Intrinsically 
disordered regions (IDRs) have in common several 
characteristics such as flexibility, β-sheet propensity, 
low average hydrophobicity and high net charge; these 
features are hallmarks of IDPs and have been used to 
develop specific predictors of disorder [1]. 
IDPs can be considered “promiscuous”, as they can 
bind through several interactions, different targets [7]. 
Binding of IDPs to partners may result in formation of 
highly dynamic complexes [8-10] or be accompanied by a 
folding process with a generation of an ordered structure. 
This latter process allows IDPs to gain a particular 
biological function. 
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2.2  Chemicals
All solvents were reagent grade. Nα-Fmoc-protected 
amino acids and activating agents were purchased from 
Inbios (Pozzuoli, Italy), Nα-Fmoc-protected-D-phospho-
Threonine (pt) and Nα-Fmoc-protected-L-phospho-
Serine (pS) from AnaSpec, Inc. (Fremont, CA). Resin for 
peptides synthesis was purchased from Novabiochem 
(Läufelfingen, Switzerland). All other chemicals were 
commercially available from Sigma-Aldrich, Fluka (Buchs, 
Switzerland) or LabScan (Stillorgan, Dublin, Ireland) 
and were used as received, unless otherwise stated. 
HPLC chemicals were purchased from Lab-Scan (Dublin, 
Ireland). 
2.3  Peptide synthesis 
IDP-phosphopeptides and IDP-allyl-glycine (see Table 1) 
were synthesized in batch by using standard solid-phase 
9-fluorenylmethoxycarbonyl (Fmoc) procedures [15] on 
Rink-amide 4-methylbenzhydrylamine (MBHA) resin 
(0.65 mmol g-1, 0.020 mmol scale). Peptide elongation 
was achieved by sequential addition of Fmoc-AA-OH 
using 1-hydroxybenzotriazole (HOBt)/ O-benzotriazole-
tetramethyl-uronium-hexafluoro-phosphate (HBTU)/
diisopropylethylamine (DIPEA) (1/1/2 v/v/v) as coupling 
reagents, in dimethylformamide (DMF) in preactivation 
mode. All couplings were performed for 30 minutes, 
by using an excess of 5 equivalents for the single 
amino acid derivative. Fmoc removal was achieved by 
piperidine/DMF (3:7, v/v) treatment for 10 min. Peptides 
deprotection and cleavage from the solid support were 
achieved by treatment with a trifluoroacetic acid (TFA)/
triisopropylsilane (TIS)/water (95/2.5/2.5, v/v/v) mixture 
for 90 min at room temperature. The crude peptides were 
precipitated at 0 °C with ethyl ether, dissolved in a water/
acetonitrile (1:1, v/v) mixture and lyophilized. Crude 
products were purified by RP-HPLC chromatography. 
Preparative RP-HPLCs were carried out on a LC8 Shimadzu 
HPLC system (Shimadzu Corporation, Kyoto, Japan) 
Interestingly, it has been reported that several 
peptides, such as the CCK8, to interact selectively with 
their receptors require an initial disordered conformation 
[11].
For the coupled “binding-folding” of IDPs a “fly-
casting” mechanism has been proposed that is basically 
responsible for enhanced interaction kinetics [12,13]. In 
contrast to ordered proteins, the large chain flexibility 
in IDPs supplies a bigger capture radii; according to the 
“fly-casting” model, a flexible region, that represents the 
unfolded state, will first interact partially and weakly with 
its target relatively far from the binding site and then, will 
fold while approaching to it [13].
IDPs often contain post-translational modifications 
(PTM), such as phosphorylation, that can stimulate 
structural rearrangements. It is hypothesized that the 
location of PTM sites in proximity of a disordered segment 
may facilitate the binding of the enzyme catalyzing the 
PTM in several targets [1,5].
To get better understanding of the complex machineries 
that govern molecular recognition processes involving 
IDPs, we have undertaken studies of predicted unstructured 
peptides (See Table 1). In major detail, peptide sequences 
enriched in disorder promoting amino acids [1] flanked 
at either the N- or C-terminal end by a phosphorylated 
residue, were designed and synthesized by solid phase 
synthesis methods. In addition, the conformational 
behavior of the following unphosphorylated peptide 
sequence (IDP), NH2-AQIREASSPSLQVDNQSDQTg-CONH2 
(g=Allyl-glycine), was also investigated. The absence of 
one single ordered conformation in these peptides was 
established experimentally by CD and NMR analyses that 
were conducted under different solution conditions (i.e.: 
aqueous buffer, water/trifluoroethanol (TFE) mixtures, 
dimethylsulfoxide (DMSO)).
These peptides may represent new disordered 
scaffolds which, by preserving most of the advantages 
of IDPs, could eventually take part in several molecular 
recognition processes and exert biological actions.
2  Experimental Procedures
2.1  Disorder prediction
A peptide sequence with a high disorder propensity, i.e. 
a region enriched in “disorder promoting residues” (A, R, 
Q, S, P and E) [1] was designed and checked for disorder 
prediction using the MeDor metaserver (http://www.
vazymolo.org/MeDor/index.html) [14].
Peptide Sequences MW (Da)
IDP1 NH2-AQIREASSPSLQVDNQSDQpt-CONH2 2254.2
IDP2 NH2-ptAQIREASSPSLQVDNQSDQT-CONH2 2355.4
IDP3 NH2-pSAQIREASSPSLQVDNQSDQT-CONH2 2341.4
IDP    NH2-AQIREASSPSLQVDNQSDQTg-CONH2 2270.2
Table 1.  Peptide sequences and their molecular weight.
pt=D-phospho-Threonine; pS=L-phospho-Serine, g=Allyl-glycine
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equipped with an UV lambda-Max Model 481 detector, by 
using a Phenomenex (Torrance, CA) -C18 Jupiter column 
(90 Å; 10 mm) and by using as elution solvents  0.1% 
TFA in water (a) and 0.1% TFA in acetonitrile (b) from 5 
to 70% over 30 min (flow rate: 20 mL/min). Peptides 
purity and integrity were assessed by analytical LC–MS 
analysis with a Finnigan Surveyor MSQ single quadrupole 
electrospray ionization spectrometer (Finnigan/ Thermo 
Electron Corporation San Jose, CA), by eluting with 0.1% 
TFA in water (a) and 0.1% TFA in acetonitrile (b) from 5 
to 70% over 15 min (0.8 mL/min). Characterization was 
conducted under standard conditions of peptide analysis. 
The expected and experimental mass of our peptides are 
the following: M.W. IDP1=2254.2 Da and [M+2H+]/2=1128.1 
m/z; M.W. IDP2=2355.4 Da and [M+2H+]/2=1178.7 m/z; M.W. 
IDP3=2341.4 Da and [M+2H+]/2=1171.7 m/z; M.W. IDP= 
2270.2 Da and [M+2H+]/2= 1135.1 m/z.
2.4  Circular dichroism measurements
Far-UV CD spectra of IDP1 were recorded from 190 to 260 
nm on a Jasco J-810 spectropolarimeter equipped with 
a NesLab RTE111 thermal controller unit using a 0.1 cm 
quartz cell at 25 °C. Circular dichroism measurements 
were carried out on peptide solutions at 1·10-4 M 
concentration. Solutions were prepared by promptly 
dissolving lyophilized pure peptide powder in net H2O 
at a final pH ~ 5 (the acidic pH was due to the residual 
TFA used during peptide cleavage and purification). CD 
spectra were also recorded for an IDP1 sample dissolved 
in a mixture of water/trifluoroethanol (TFE) (50/50) and of 
water/TFE (25/75). 
Other experimental settings were: scan speed, 10 nm 
min-1; sensitivity, 50 mdeg; time constant, 4 s; bandwidth, 
2 nm. Each spectrum was obtained by averaging three 
scans, subtracting contributions from other species 
in solution and converting the signal to mean residue 
ellipticity in units of deg cm2 dmol-1 res-1.
2.5  Nmr measurements and solution structure 
calculations
NMR analysis was performed for IDP, IDP1, IDP2 and IDP3. 
NMR samples were prepared by dissolving about 0.5 mg 
of each peptide in a solution volume equal to 600 µL. 
NMR analysis of IDP1 was performed in H2O containing 
10% v/v D2O (99.8% d, Armar Scientific, Switzerland) 
and in a mixture H2O/trifluoroethanol-d3 (98% d, Armar 
Chemicals, Switzerland) 17/83 v/v. Solution conformational 
studies of IDP were conducted in H2O/trifluoroethanol-d3 
(98% d, Armar Chemicals, Switzerland) 17/83 v/v. NMR 
characterizations of IDP2 and IDP3 were carried out in 
DMSO-d6 (99.9% d, Armar Chemicals, Switzerland).
NMR spectra were recorded at 25 °C on a Varian 
Unity Inova 600 MHz spectrometer provided with a cold 
probe. The process of proton resonance assignments 
(See Supplemental Tables S1, S2, S3 and S4) was carried 
out with a canonical protocol [16] based on analysis of 
the following two dimensional [1H, 1H] spectra: TOCSY 
(Total Correlation Spectroscopy) (70 ms mixing time) 
[17], DQFCOSY (Double Quantum Filter Correlation 
Spectroscopy) [18], NOESY (Nuclear Overhauser 
Enhancement Spectroscopy) [19] (200 and 300 ms mixing 
times). Chemical shifts were referenced with respect to the 
TSP (Trimethylsilyl-3-propionic acid sodium salt-d4, 99% 
d, Armar Scientific, Switzerland) signal at 0.0 ppm. 
1D spectra were acquired with a relaxation delay of 1s 
and 32-128 scans. 2D experiments were generally acquired 
with 32-64 scans, 128-256 FIDs in t1, 1024 or 2048 data 
points in t2. 
The DPFGSE (Double Pulsed Field Gradient Selective 
Echo) sequence [20] was used to suppress water signal. 
Spectra were processed with the Varian software VNMRJ 
1.1D (Varian by Agilent Technologies, Italy) and analyzed 
with the NEASY [21] program that is included in the 
CARA (Computer Aided Resonance Assignment) software 
package (http://www.nmr.ch/). 
Peptide structure calculations were carried out with 
the software CYANA (version 2.1) [22]. A D-phospho-
Threonine and L-phospho-Serine were introduced in the 
CYANA standard residue library [23]. Distance constraints 
for structure calculations were gained from NOESY 
experiments (300 ms mixing time). The GRIDSEARCH 
module of CYANA was used to generate angular constraints. 
Calculations started from 100 random conformers; the 20 
conformers with the lowest CYANA target functions were 
finally checked with the program MOLMOL [24] and iCing 
(http://proteins.dyndns.org/cing/iCing.html) [25].
3  Results and Discussion
Four intrinsically-disordered peptides (IDP, IDP1, IDP2 
and IDP3; see Table 1) were designed and analyzed. Their 
primary sequences include a predicted disordered region 
(-AQIREASSPSLQVDNQSDQ-) (See also Material and Methods 
for details ) and a phosphorylated amino acid at C-terminus 
(IDP1 with phospho-Threonine) or N-terminus (IDP2 
with phospho-Threonine and IDP3 with phospho-Serine, 
respectively) or an Allyl-glycine at the C-terminus (IDP).
The high disorder propensity of the common 
-AQIREASSPSLQVDNQSDQ- peptide core was evaluated 
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with the MeDor server [14] (Supplemental Figure S1, upper 
panel) while its tendency towards β-aggregation was 
investigated with the software TANGO [26] which indicated 
that its sequence is not inclined to form β-aggregates 
(Supplemental Figure S1, lower panel).
Conformational features of IDP, IDP1, IDP2 and IDP3 
were studied in solution by CD and NMR techniques.
3.1  Circular Dichroism
CD spectra of IDP1 in water and in the water/TFE mixtures 
(50/50 and 25/75 v/v) were recorded between 190 and 260 
nm. IDP2 and IDP3 peptide sequences were not soluble 
under the same experimental conditions. The shape of CD 
spectrum of IDP1 in water, with a negative band between 
197 and 201 nm, suggests an unordered structure (see 
Figure 1A). The addition of TFE induces a conformational 
rearrangement from random coil to β-structure. This 
rearrangement can be better appreciated by difference 
spectra (Figure 1B), which show a pronounced negative 
maximum around 220 nm and a positive maximum around 
200 nm, which are characteristic of β-sheet conformation. 
However, the low structural content gained by the peptide, 
even in TFE, supports its high flexibility. Similar CD 
spectra were also detected for the unphosphorylated IDP 
peptide at different water/TFE ratios (data not shown).
3.2  NMR studies
Detailed NMR studies of IDP, IDP1, IDP2 and IDP3, 
including acquisition and analysis of 1D [1H] and 2D [1H, 
1H] spectra, were conducted at 25°C. 
We first investigated the conformational preferences 
of IDP1 in H2O/D2O (90/10 v/v). Under these experimental 
conditions, the poor spectral dispersion of the 1D [1H] 
spectrum (Figure 2A) and the almost complete absence 
of signal in the 2D [1H, 1H] NOESY experiment indicated 
that IDP1 was very flexible and disordered (Supplemental 
Figure S2A). 
Next we treated IDP1 with TFE that is a useful 
co-solvent to investigate the inherent conformational 
preferences of proteins and peptides [27] and has already 
been used in IDPs studies [28-30]. Since CD data indicated 
a gain of structure in IDP1 only at high TFE concentration, 
we conducted NMR characterization of the peptide in 
presence of 83% TFE.
A gain of ordered structure induced by TFE can 
already be appreciated in the HN region of the 1D proton 
experiment (Figure 2A) where an improvement of the 
spectral dispersion is evident. Nevertheless, many cross-
peaks appear in the 2D [1H, 1H] NOESY spectrum as well 
(Figure 2C) possibly indicating a decrease of flexibility 
in the peptide. The high quality of the spectra, recorded 
in presence of TFE, allowed us to carry out a complete 
structural characterization and obtain proton resonance 
assignments (Figure 2 and Supplemental Table S1). We 
evaluated chemical shift deviations (CSD) of Hα protons 
from random coil values (Supplemental Figure S3) and 
noticed that they did not point to any specific secondary 
structure element. In fact, most of the CSD were low 
(i.e. with absolute values lower that 0.1) and positive 
(positive deviations are generally indicative of extended 
conformations) [31]. Afterwards, we analyzed short and 
medium range NOEs (Figures 3A and S4). For most of IDP1 
Figure 1. Far UV CD spectra of: A) IDP1 at 0, 50 and 75% of TFE and of B) IDP1 at 50% (solid line) and 75% (dash line) of TFE after subtraction 
of IDP1 at 0% TFE.
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Figure 2.  (A) Overlay of 1D proton spectra of IDP1 recorded in H2O/D2O (90/10 v/v) (red) and in H2O/TFE-d3 (17/83 v/v) (blue). (B) 2D [1H, 
1H] TOCSY and (C) 2D [1H, 1H] NOESY 300 spectra of IDP1 acquired in H2O/TFE-d3 (17/83 v/v); the HN/aliphatic protons correlation 
regions of both spectra are shown; spin system assignments are indicated in (B).
primary sequence sequential NOE contacts of the type Hαi-
HNi+1 (indicated as dαN(i, i+1)  in Fig. 3A), Hβi-HNi+1 (dβN(i, i+1)  in 
Fig. 3A) and HNi-HNi+1 (dNN(i, i+1) in Fig. 3A) are predominant 
and not clearly indicative of any ordered conformation [16]. 
Interestingly,  the NOE pattern improves in the segment 
encompassing residues from Ser10 to Gln16, where 
medium range contacts typical of helical structures (i.e. 
dαβ(i, i+3) and dαΝ(i, i+3)) can be observed [16]. The Pro residue is 
mainly in trans configuration as shown by the strong NOE 
cross peak in between the Hα proton of Ser8 and the Hδ 
protons of Pro9, however, a weaker NOE between the Hα 
protons of Ser8 and Pro9 is evident as well and points to 
some proline cis-trans isomerization [16].
Indeed, structural calculations, carried out with 
the software CYANA [22] (See Table 2 and Figure 3), 
demonstrate that the peptide is rather flexible and assumes 
a more ordered pseudo-helical turn only between residues 
Val13 and Gln16 (Figure  3B,C). This small helical/turn 
contribution to the overall IDP1 disordered conformation 
in TFE cannot be appreciated by CD experiments which 
mainly underline the prevalence of extended structures 
(Figure 1). 
The disorder of the peptide is represented by the 
high RMSD values measured for the NMR ensemble 
(Figure 3B and Table 2). In summary, these data, in 
agreement with CD results, indicate that the propensity 
of IDP1 to gain an ordered secondary structure is rather 
low even under strong structuring conditions (i.e. high 
percentage of TFE in solution). For comparison purpose, 
we also carried out similar NMR studies in aqueous 
solution, containing 83% TFE, of the analogue peptide: 
AQIREASSPSLQVDNQSDQTg (where g= Allyl-glycine) 
which lacks a phosphorylated residue (Supplemental 
Figure S5 and Table S2). This peptide exhibits identical 
conformational behavior as IDP1, as indicated by similar 
CD spectrum (data not shown) and NMR parameters 
such as CSD (Supplemental Figure S6) and NOE pattern 
(Supplemental Figure S7). These data likely demonstrate 
that the presence of a phosphate group does not 
dramatically influence the overall conformational 
disorder of our IDP peptides.
Attempts to carry out structural studies of IDP2 and 
IDP3 in water and in water/TFE mixtures were hampered 
by the low solubility of both peptides. Thus, we analyzed 
their structural features in DMSO, a solvent in which it 
was possible to record high quality NMR data (Figures 
4 and 5) and obtain proton resonance assignments 
(Supplemental Tables S3 and S4). In DMSO, IDP2 and 
IDP3 show a very similar conformational behavior. 2D 
[1H, 1H] NOESY spectra of both peptides (Figure 4B and 
5B) contain many cross-peaks and resemble typical 
experiments recorded for rigid folded species. Detailed 
analysis of NOE patterns reveals a clear prevalence 
of sequential contacts, such as Hαi-ΗNi+1, Hβi-HNi+1, 
HNi-HNi+1, (See Figure 4C) that alone are not sufficient 
to indicate any specific ordered secondary structure 
element [16]. However, these kinds of NOEs co-exist with 
several medium range contacts in between side chain 
protons two residues apart in the sequence, and with 
sequential Hα-Hα contacts, the latter are concentrated 
in the peptide region 15-DNQSDQ-20, and are generally 
more characteristic of beta type structures. Moreover, in 
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analogy with the IDP1 peptide, the Pro residue in IDP2 
and IDP3 contributes to the overall disorder. Indeed the 
trans configuration is predominant but some cis-trans 
interconversion is evident as well [16]. Tentative complete 
structure calculations were carried out and demonstrated 
the intrinsic conformational disorder of IDP2 and IDP3 
(See Figure S8). The presence of several types of NOEs 
in the spectra of IDP2 and IDP3 may indeed point to 
the occurrence of either inter-conversion of unfolded 
and partially ordered states or towards aggregation 
processes that lower the flexibility of the two peptides 
in DMSO. It’s worth nothing that many intrinsically 
disordered peptides exhibit high tendency to aggregate, 
and in fact, under physiological conditions, are able to 
form beta fibrils (“amyloids”) [32,33] and play roles in 
pathological processes like Alzheimer’s and Parkinson’s 
diseases [34-36]. Based only on the low computationally 
predicted tendency towards β-aggregation of the peptide 
core -AQIREASSPSLQVDNQSDQ- (Supplemental Figure 
S1, lower panel), this latest scenario appears unlikely 
for IDP2 and IDP3. On the other side, we cannot exclude 
that the addition of a phosphorylated amino acid may 
change the predicted aggregation propensity and/or the 
implemented non physiological conditions may favor 
peptide aggregation.
4  Conclusions
IDPs represent targets in drug discovery for several diseases 
(for example tumor, Parkinson’s disease, Alzheimer’s 
disease, type II diabetes) [5,6,37]. In order to create novel 
and efficient drug discovery strategies for such proteins, 
it is essential to fully unveil distinctive characteristics of 
intrinsically disordered regions. To this aim we designed 
and synthesized three intrinsically disordered peptides, 
made up of a predicted disordered segment flanked at 
either the N- and C-terminal side by a phospho-Serine or 
a phospho-Threonine (See Table  1). We performed NMR 
Figure 3.  (A) NOE intensity pattern for IDP1 in H2O/TFE-d3. Only prin-
cipal short and medium range NOEs are reported. Different 
residues are specified with the one-letter amino acid code; 
“dξζ (b, c)” designates a NOE contact between the Hξ and Hζ 
protons in the b and c residues respectively. (B) Overlay on 
the backbone atoms (residues 12-18, RMSD=0.70 ± 0.33 Å) 
of 20 IDP1 structures. (C) Ribbon representation of the best 
IDP1 CYANA conformer (i.e. the one with the lowest target 
function). The D-phospho-Threonine side chain is reported 
in neon representation. The final CYANA calculation 
included 143 upl (upper distance limits) of which 60 intra-
residue, 73 short- and 10 medium-range.
NOE upper distance limits 143
Angle constraints 88
Residual target function, Å2 0.22±0.07
Residual NOE violations
Number > 0.1 Å# 2
Number 7
Residual angle violations
Number 0
Atomic pairwise RMSD@, Å
Backbone atoms (a.a. 2-19) 2.39±0.54
Heavy atoms (a.a. 2-19) 3.57±0.66
Table 2.  Structure statistics for the IDP1 NMR ensemble calculated 
in H2O/TFE-d3 (17/83 v/v).
# Average CYANA violation; @Calculated by iCing
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non physiological conditions, IDP2 and IDP3 exhibited 
identical conformational behavior, characterized by 
the absence of one single ordered state and probably by 
aggregation phenomena.
As concerning the possible applications of the 
disordered IDP1, IDP2 and IDP3 peptides, we can certainly 
envision their use to generate novel peptide amphiphiles 
(PAs) to be implemented in the field of biomedicine and 
biocompatible materials [11,38-41].
In fact, we have very recently described novel PAs, 
obtained by coupling an intrinsically disordered short 
peptide to different alkyl-chains, that are able to self-
assemble in supramolecular aggregates (i.e., unilamellar 
vesicles and micelles) with a consequent reduction of 
flexibility and a gain of structure with respect to the free 
peptide [41]. 
Moreover, we cannot exclude that our IDP1, IDP2 and 
IDP3 peptides, being provided with characteristic features 
of intrinsically disordered proteins, may take part in 
different protein-protein interaction networks and have a 
particular biological action, but of course deep studies in 
a cellular environment are needed to prove this scenario.
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and CD solution conformational studies. In particular we 
first analyzed the peptide IDP1, that contains a phospho-
Threonine at the C-terminal end. The absence of precise 
secondary structure elements was proved in water 
and water/TFE mixtures. The addition of TFE in high 
percentage only slightly decreases IDP1 conformational 
flexibility thus stressing out the natively disordered 
nature of this peptide. The same conformational trend in 
a solution containing TFE, is exhibited by the analogue 
unphosphorylated IDP peptide (See Table 1); these data 
likely indicate that phosphorylation does not affect 
relevantly the structure of our peptides.
We next analyzed IDP2 and IDP3 whose primary 
sequences differ only in the first N-terminal residue: 
either a phospho-Threonine or a phospho-Serine. 
Solubility issues did not allow us to characterize these 
two peptides in aqueous buffer, we thus investigated 
their conformational preferences in DMSO. Under these 
Figure 4.  Comparison of (A) 2D [1H, 1H] TOCSY and (B) NOESY 300 
spectra of IDP2 recorded in DMSO-d6. The HN correlation 
regions of the spectra are shown. (C) NOE intensity pattern 
for IDP2.
Figure 5.  Expansion of a region of (A) 2D [1H, 1H] TOCSY and (B) 2D 
[1H, 1H] NOESY 300 of  IDP3 where correlations arising from 
HN protons can be observed. Spectra were acquired in 
DMSO-d6. 
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